HD-OPM Archive
Topics › Statins

LODESTAR: rosuvastatin and atorvastatin had comparable outcomes in 4,400 patients with CAD

Louis Nervegna · Jul 17, 2024 · ♥ 12 reactions · 6 comments · original Facebook post
StatinsHeart attack, stroke & procedures
AI summary & key facts

In the head-to-head LODESTAR trial, rosuvastatin and atorvastatin showed comparable three-year rates of death, MI, stroke or revascularization in patients with coronary artery disease. Rosuvastatin lowered LDL more but had higher new-onset diabetes needing treatment and cataract surgery.

Which statin drug is best for lowering risk of heart attack, stroke, and all cause mortality in higher risk patients?

The recently published LODESTAR randomized trial directly compared Rosuvastatin (Crestor) and Atorvastatin (Lipitor) head to head.

Here are the results:

“Conclusions: In adults with coronary artery disease, rosuvastatin and atorvastatin showed comparable efficacy for the composite outcome of all cause death, myocardial infarction, stroke, or any coronary revascularisation at three years. Rosuvastatin was associated with lower LDL cholesterol levels but a higher risk of new onset diabetes mellitus requiring antidiabetics and cataract surgery compared with atorvastatin.”

This trial was run in 12 hospitals in South Korea, September 2016 to November 2019 in 4400 adults (age ≥19 years) with coronary artery disease. Participants were assigned to receive either rosuvastatin (n=2204) or atorvastatin (n=2196) using 2×2 factorial randomisation. The primary outcome was a three year composite of all cause death, myocardial infarction, stroke, or any coronary revascularisation.

#statinsHD #rosuvastatinHD #atorvastatinHD

PaperThe BMJ articleObjective To compare the long term efficacy and safety of rosuvastatin with atorvastatin treatment in adults with coronary artery disease. Design Randomised, open label, multicentre trial. Setting 12 hospitals in South Korea, September 2016 to November 2019. Participants 4400 adults (age ≥19 years...bmj.com

Research cited

← newer: MESA: high Lp(a) mostly matters when CAC is 100 or aboveolder: Blocking IL-11 extended mouse lifespan ~25%; diets and drugs →